Cetuximab Pharmacokinetics Influences Overall Survival in Patients With Head and Neck Cancer. (Record no. 26421594)

MARC details
000 -LEADER
fixed length control field 01417 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517114659.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201711s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1536-3694
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1097/FTD.0000000000000321
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Pointreau, Yoann
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20171117
245 00 - TITLE STATEMENT
Title Cetuximab Pharmacokinetics Influences Overall Survival in Patients With Head and Neck Cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Therapeutic drug monitoring
Date of publication, distribution, etc. 10 2016
300 ## - PHYSICAL DESCRIPTION
Extent 567-72 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Squamous Cell
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cetuximab
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Head and Neck Neoplasms
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Models, Biological
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retrospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Squamous Cell Carcinoma of Head and Neck
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Azzopardi, Nicolas
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ternant, David
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Calais, Gilles
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Paintaud, Gilles
773 0# - HOST ITEM ENTRY
Title Therapeutic drug monitoring
Related parts vol. 38
-- no. 5
-- p. 567-72
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1097/FTD.0000000000000321">https://doi.org/10.1097/FTD.0000000000000321</a>
Public note Available from publisher's website

No items available.